{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:05:24Z","timestamp":1762985124061,"version":"3.45.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jdin.2021.12.009","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T00:34:35Z","timestamp":1640651675000},"page":"107-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5423-0635","authenticated-orcid":false,"given":"Xiaotian","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel Hua Liang","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce Siong See","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin Tze-Wei","family":"Chio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdin.2021.12.009_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/000155501750208128","article-title":"Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum","volume":"81","author":"Labunski","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jdin.2021.12.009_bib2","doi-asserted-by":"crossref","unstructured":"Sahin U, Muik A, Derhovanessian E, et\u00a0al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature. 2020;586(7830):594-599. Published correction appears in Nature. 2021;590(7844):E17. https:\/\/doi.org\/10.1038\/s41586-020-2814-7","DOI":"10.1038\/s41586-020-03102-w"},{"issue":"1","key":"10.1016\/j.jdin.2021.12.009_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/187152809787582543","article-title":"TNF-alpha in tuberculosis: a cytokine with a split personality","volume":"8","author":"Mootoo","year":"2009","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.jdin.2021.12.009_bib4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/annrheumdis-2021-eular.860","article-title":"POS0422 Panniculitis as a manifestation of an autoimmune\/autoinflammatory disease","volume":"80","author":"Egorova","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jdin.2021.12.009_bib5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.31138\/mjr.28.2.64","article-title":"The ASIA syndrome: basic concepts","volume":"28","author":"Watad","year":"2017","journal-title":"Mediterr J Rheumatol"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328721001115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328721001115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:59:34Z","timestamp":1762981174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328721001115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":5,"alternative-id":["S2666328721001115"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2021.12.009","relation":{},"ISSN":["2666-3287"],"issn-type":[{"type":"print","value":"2666-3287"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2021.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}